FDA Investigator

Rafeeq A Habeeb

Latest inspection on record: Dabhel, Daman, India, April 2026 · records back to 2018

Human DrugsFoods & CosmeticsAnimal Drugs & FeedsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 84 inspections across 82 sites are on record.
  • 252 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-17.

At a glance

Inspections

84

Sites

82

Observations

252

Career since

Sep 2018

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
USV Private Limited17 Apr 2026Human DrugsOn file
Acme Generics Private Limited20 Feb 2026Human DrugsOn file
Dabur India Limited16 Jan 2026Human DrugsOn file
APL HEALTHCARE LIMITED17 Dec 2025Human DrugsOn file
Zydus Lifesciences Limited13 Nov 2025Human DrugsOn file

Sites inspected

USV Private LimitedDabhel, Daman, India1 insp.
Acme Generics Private LimitedSolan, India1 insp.
Dabur India LimitedDadra And Nagar Haveli, India1 insp.
APL HEALTHCARE LIMITEDNaidupeta, India1 insp.
Zydus Lifesciences LimitedMatoda, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Rafeeq A Habeeb's 252 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators